Mimotopes is proud to announce its participation in the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting & Pre-Conference Programmes, held from 6-10 November 2024 at the George R Brown Convention Center in Houston, Texas, and virtually. Visit Mimotopes at Booth 1021.
SITC 2024 is a premier event dedicated to advancing the science of cancer immunotherapy, providing a collaborative platform for researchers, clinicians, industry professionals, and early career scientists to share breakthroughs and network with global leaders in the field.
Mimotopes has been at the forefront of peptide innovation for over 30 years, offering custom peptide synthesis, peptide libraries, and epitope mapping services. Our solutions cater to every stage of drug discovery, from synthesis to therapeutics, making us the one-stop shop for all peptide needs.
Attendees will have the opportunity to explore how Mimotopes’ expertise in peptide synthesis can enhance their cancer immunotherapy research, with services including:
- Custom peptide synthesis and catalogue peptides
- B- and T-cell epitope mapping services
- Custom peptide libraries
- Peptide synthesis reagents
- Price matching and technical expertise
Join Mimotopes at SITC 2024 to learn how our tailored peptide solutions can support your next breakthrough in immunotherapy and help bring the word ‘cure’ closer to reality for cancer patients worldwide. To register for the conference, please click here.